<DOC>
	<DOCNO>NCT01241305</DOCNO>
	<brief_summary>The purpose study identify gene increase risk develop vasculitis , group severe diseases feature inflammation blood vessel . Results study provide vasculitis researcher insight cause disease generate new idea diagnostic test therapy , great interest large community researcher investigate vasculitis autoimmune , inflammatory , vascular disease .</brief_summary>
	<brief_title>One-Time DNA Study Vasculitis</brief_title>
	<detailed_description>The systemic vasculitides comprise several inflammatory disease blood vessel , usually artery , may cause systemic , multi-organ disease result substantial morbidity increase mortality . Each type vasculitis rare ( `` orphan '' ) disease . However , take together , vasculitis affect tens thousand Americans responsible substantial morbidity mortality almost one billion dollar per year hospital care alone . While vasculitides share trait vascular inflammation , unique disease phenotype , clinical course , difference prognosis , response therapy suggest important difference exist pathogenesis . The Vasculitis Clinical Research Consortium ( VCRC ) currently focus 6 specific type vasculitis select represent balance unmet medical scientific need , prevalence North America , feasibility study , interest study spectrum small , medium , large vessel vasculitides . The great majority publish study genetics vasculitis use modest-sized cohort suitable investigation candidate gene time , detect large effect size , replicate finding highly skew HLA region . Larger ambitious genetic study vasculitis expect generate numerous hypothesis translational research gene expression , biochemistry , molecular pathology . A one-time collection clinical data DNA would substantially increase sample size genetic association study six vasculitides study VCRC . Many patient see participate VCRC center enroll Longitudinal Studies . These patient often interested participate research study return frequently visit , usually due distance VCRC center . This approach would particularly useful rarer form vasculitis study ( Takayasu 's Arteritis ( TAK ) , Polyarteritis Nodosa ( PAN ) , eosinophilic granulomatosis polyangiitis ( Churg-Strauss ) ( EGPA ) also Giant Cell Arteritis ( GCA ) , since elderly patient particularly likely decline participation Longitudinal Studies due travel constraint .</detailed_description>
	<mesh_term>Vasculitis</mesh_term>
	<mesh_term>Arteritis</mesh_term>
	<mesh_term>Systemic Vasculitis</mesh_term>
	<mesh_term>Giant Cell Arteritis</mesh_term>
	<mesh_term>Polymyalgia Rheumatica</mesh_term>
	<mesh_term>Granulomatosis Polyangiitis</mesh_term>
	<mesh_term>Churg-Strauss Syndrome</mesh_term>
	<mesh_term>Microscopic Polyangiitis</mesh_term>
	<mesh_term>Takayasu Arteritis</mesh_term>
	<mesh_term>Aortic Arch Syndromes</mesh_term>
	<mesh_term>Polyarteritis Nodosa</mesh_term>
	<criteria>1 . Diagnostic criterion Giant Cell Arteritis Age disease onset &gt; 50 year ( require ) 1 . New onset new type localize pain head 2 . Temporal artery abnormality ( i.e . temporal artery tenderness palpation decrease pulsation , unrelated arteriosclerosis cervical artery ) 3 . ESR &gt; 40mm first hour Westergren method 4 . Abnormal artery biopsy ( i.e . temporal artery biopsy show vasculitis characterize predominance mononuclear cell infiltration granulomatous inflammation , usually multinucleated giant cell ) 5 . Large Vessel Vasculitis ( LVV ) angiogram biopsy explain something else 2 . Diagnostic criterion Takayasu 's Arteritis 1 . Age disease onset &lt; 50 year 2 . Claudication extremities 3 . Decreased brachial artery pulse ( one artery ) 4 . Blood pressure difference &gt; 10mm Hg arm 5 . Bruit subclavian artery aorta 6 . Arteriogram abnormalities compatible TAK ( include conventional dye angiography MR angiography CT angiography ) 3 . Diagnostic criterion Polyarteritis Nodosa Major criterion ( explained cause ) felt investigator due vasculitis 1 . Arteriographic abnormality 2 . Presence granulocyte mixed leukocyte infiltrate arterial wall biopsy 3 . Mononeuropathy polyneuropathy Minor criterion ( explained cause ) felt investigator due vasculitis 1 . Weight loss &gt; 4 kg 2 . Livedo reticularis , cutaneous ulceration , skin nodule 3 . Testicular pain tenderness 4 . Myalgias 5 . Diastolic blood pressure &gt; 90 mm Hg 6 . Elevated BUN serum creatinine level 7 . Ischemic abdominal pain Isolated cutaneous Polyarteritis Nodosa 1 . Biopsyproven cutaneous PAN 4 . Diagnostic criterion Granulomatosis Polyangiitis ( Wegener 's ) ( GPA ) Microscopic Polyangitis ( MPA ) Diagnosis GPA MPA . Widely accept diagnostic criterion , oppose classification criterion definition , develop GPA &amp; MPA . For diagnosis GPA meet least 2 follow 5 modified ACR criterion : 1 . Nasal oral inflammation oral ulcer nasal discharge pu blood 2 . Abnormal chest radiograph nodule , fix infiltrates , cavity 3 . Urinary sediment microhematuria red cell cast 4 . Granulomatous inflammation within wall artery perivascular area biopsy 5 . Antineutrophil cytoplasmic antibody ( ANCA ) positive enzyme immunoassay either PR3 MPOANCA For diagnosis MPA , meet Chapel Hill Consensus Conference Definition MPA : 1 . Necrotizing vasculitis , immune deposit , affect small vessel ( i.e. , capillary , venule , arteriole ) 2 . Necrotizing arteritis involve small mediumsized artery may present 3 . Necrotizing glomerulonephritis common 4 . Pulmonary capillaritis often occur 5 . Diagnostic criterion Eosinophilic Granulomatosis Polyangiitis ( ChurgStrauss ) 1 . Asthma 2 . Peak peripheral blood eosinophilia &gt; 10 % total WBC 3 . Peripheral neuropathy attributable vasculitis 4 . Transient pulmonary infiltrates chest image study 5 . Paranasal sinus abnormality nasal polyposis 6 . Eosinophilic inflammation tissue biopsy If patient 4 6 criterion lack clearcut documentation small vessel vasculitis , also eligible enrollment . General Inability give inform consent sign consent form Enrolled VCRC protocol 5502 , 5503 , 5504 , 5505 , 5506 , 5522 , 5523 Unwilling provide blood DNA collection</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Vasculitis</keyword>
	<keyword>CSS</keyword>
	<keyword>EGPA</keyword>
	<keyword>GCA</keyword>
	<keyword>GPA</keyword>
	<keyword>WG</keyword>
	<keyword>MPA</keyword>
	<keyword>PAN</keyword>
	<keyword>TAK</keyword>
</DOC>